Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EMC3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PFDN4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NDN - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COX7B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HSPA12A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PPP2R5E - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAGEE1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EID2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MKRN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARMC2-AS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BCAP29 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PGAM1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP6AP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CYCS - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GOT1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PDS5B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GOT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HIGD1A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
AMN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on